Ciprofloxacin Export Market Intelligence: India's 1001 Suppliers Shipping to 180 Countries — TransData Nexus 2026

Q: Who are the top ciprofloxacin exporters from India?

The top ciprofloxacin exporters from India are: 1. DR.REDDY'S LABORATORIES LTD — $48.5M (16.1% market share); 2. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $36.3M (12.0% market share); 3. DR REDDYS LABORATORIES LIMITED — $29.6M (9.8% market share); 4. MACLEODS PHARMACEUTICALS LTD — $12.5M (4.1% market share); 5. AUROBINDO PHARMA LTD — $11.4M (3.8% market share). Together they account for 45.9% of India's total ciprofloxacin export value.

Q: What is the total export value of ciprofloxacin from India?

The total export value of ciprofloxacin from India is $301.1M USD, recorded across 14,146 shipment transactions from 1001 active exporters to 180 destination countries. The average shipment value is $21.3K.

Q: Which countries import ciprofloxacin from India?

India exports ciprofloxacin to 180 countries worldwide. The top importing countries are: UNITED STATES (42.3% share, $127.3M), RUSSIA (7.1% share, $21.2M), VIETNAM (6.9% share, $20.8M), NIGERIA (6.1% share, $18.4M), ETHIOPIA (2.2% share, $6.6M). These five markets account for 64.6% of total export value.

Q: What is the average price of ciprofloxacin exports from India?

The average unit price for ciprofloxacin exports from India is $14.17 USD per unit, with prices ranging from $0.00 to $10480.89 depending on formulation, packaging, and order volume. The total market is valued at $301.1M across 14,146 shipments.

Q: Which ports handle ciprofloxacin exports from India?

The primary ports for ciprofloxacin exports from India are SAHAR AIR CARGO ACC (INBOM4) (12.9% of shipments), SAHAR AIR (10.5% of shipments), NHAVA SHEVA SEA (INNSA1) (8.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.8% of shipments), JNPT/ NHAVA SHEVA SEA (5.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ciprofloxacin?

India is one of the world's leading exporters of ciprofloxacin due to its large base of 1001 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ciprofloxacin to 180 countries, demonstrating 92% global market coverage.

Q: What certifications do Indian ciprofloxacin exporters need?

Indian ciprofloxacin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ciprofloxacin from India?

There are 3,081 registered buyers importing ciprofloxacin from India, spread across 180 countries. The repeat buyer rate is 52.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ciprofloxacin supplier from India?

DR.REDDY'S LABORATORIES LTD is the leading ciprofloxacin exporter from India with a market share of 16.1% and total export value of $48.5M across 54 shipments. The top 5 suppliers together control 45.9% of total export value.

Suresh Sormare

Ciprofloxacin

India Pharmaceutical Trade Intelligence

$301.1M1,001 Suppliers180 CountriesHS 30042013

ExportsIndia → UNITED STATES42.3%India → RUSSIA7.1%

ImportsUNITED STATES → India$518.1K ITALY → India$94.7K

#1 Buyer: DR REDDYS

Ciprofloxacin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ciprofloxacin to the World

Between 2022 and 2026, India exported $301.1M worth of ciprofloxacin across 14,146 verified shipments to 180 countries — covering 92% of world markets in the Antibiotics segment. The largest destination is UNITED STATES (42.3%). DR.REDDY'S LABORATORIES LTD leads with a 16.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ciprofloxacin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ciprofloxacin export data snapshot — $301.1M · 1001 exporters · 180 countriesTransData Nexus · Indian Customs Data

Top Ciprofloxacin Exporters from India

1001 active exporters · Ranked by export value

View all 1001 →

Top Ciprofloxacin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	DR.REDDY'S LABORATORIES LTD	$48.5M	54	3	16.1%
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED

Top Countries Importing Ciprofloxacin from India

180 destination markets · Ranked by import value

All 180 countries →

Top Countries Importing Ciprofloxacin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$127.3M	42.3%
2	RUSSIA	$21.2M	7.1%
3	VIETNAM	$20.8M	6.9%
4	NIGERIA	$18.4M	6.1%
5	ETHIOPIA	$6.6M	2.2%
6	SIERRA LEONE	$6.2M	2.1%
7	KENYA	$5.0M	1.6%
8	FRANCE	$4.3M	1.4%
9	TANZANIA	$4.2M	1.4%
10	CANADA	$4.1M	1.4%

UNITED STATES is India's largest ciprofloxacin export destination, absorbing 42.3% of total exports worth $127.3M. The top 5 importing countries — UNITED STATES, RUSSIA, VIETNAM, NIGERIA, ETHIOPIA — together account for 64.6% of India's total ciprofloxacin export value. The remaining 175 destination countries collectively receive the other 35.4%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Ciprofloxacin to India?

17 origin countries · Total import value: $701.1K

India imports ciprofloxacin from 17 countries with a combined import value of $701.1K. The largest supplier is UNITED STATES ($518.1K, 76 shipments), followed by ITALY and BELGIUM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Ciprofloxacin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$518.1K	76	73.9%
2	ITALY	$94.7K	3	13.5%
3	BELGIUM	$58.5K	2	8.3%
4	GERMANY	$15.9K	21	2.3%
5	MALTA	$3.5K	6	0.5%
6	UNITED KINGDOM	$3.4K	4	0.5%
7	HUNGARY	$2.0K	27	0.3%
8	GREECE	$1.6K	1	0.2%
9	CANADA	$1.0K	8	0.1%
10	GUYANA	$875	1	0.1%

Showing top 10 of 17 origin countries

UNITED STATES is the largest supplier of ciprofloxacin to India, accounting for 73.9% of total import value. The top 5 origin countries — UNITED STATES, ITALY, BELGIUM, GERMANY, MALTA — together supply 98.5% of India's ciprofloxacin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Ciprofloxacin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, ciprofloxacin is approved for various indications, including urinary tract infections and respiratory tract infections. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for ciprofloxacin, reflecting its established presence in the U.S. market. The regulatory pathway for ciprofloxacin involves rigorous evaluation of bioequivalence and manufacturing standards to ensure safety and efficacy. Given that 42.3% of India's ciprofloxacin exports are directed to the U.S., Indian exporters must adhere to stringent FDA regulations, including compliance with Current Good Manufacturing Practices (cGMP) and potential inspections. The substantial number of active Indian exporters underscores the competitive landscape and the importance of maintaining high regulatory standards to ensure market access.

2EU & UK Regulatory Framework

In the European Union, ciprofloxacin is subject to marketing authorization by the European Medicines Agency (EMA). The EMA evaluates applications based on quality, safety, and efficacy criteria. Manufacturers must comply with EU Good Manufacturing Practice (GMP) guidelines, which are harmonized across member states to ensure consistent quality standards. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization and regulation of medicinal products, including ciprofloxacin. Post-Brexit, the UK has established its own regulatory framework, though it remains closely aligned with EU standards. Indian exporters targeting these markets must ensure compliance with both EMA and MHRA requirements, including adherence to GMP standards and submission of comprehensive dossiers demonstrating product quality and efficacy.

3WHO Essential Medicines & Global Standards

Ciprofloxacin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in addressing priority health needs globally. The 24th edition of the WHO Model List, published in September 2025, continues to list ciprofloxacin as an essential medicine. This inclusion highlights the antibiotic's importance in treating a range of bacterial infections. Furthermore, ciprofloxacin is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality specifications across different regions. Compliance with these pharmacopoeial standards is essential for manufacturers to meet international quality requirements and facilitate global trade.

4India Regulatory Classification

In India, ciprofloxacin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. This classification mandates that ciprofloxacin can only be sold or dispensed with a valid prescription from a registered medical practitioner. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including ciprofloxacin, to ensure affordability and accessibility. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations and monitoring of drug exports.

5Patent & Exclusivity Status

The primary patents for ciprofloxacin have expired, leading to the availability of generic versions in various markets. This patent expiration has facilitated increased competition among manufacturers, contributing to the widespread availability and affordability of ciprofloxacin globally. Indian pharmaceutical companies have capitalized on this opportunity, becoming significant suppliers of generic ciprofloxacin to international markets.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines convened to update the Model List of Essential Medicines, reaffirming the inclusion of ciprofloxacin due to its continued relevance in treating bacterial infections. This endorsement reinforces the antibiotic's essential status in global health.

In January 2026, the WHO published a fact sheet emphasizing the importance of essential medicines, including ciprofloxacin, in addressing priority health care needs. The document highlighted the necessity for these medicines to be available, affordable, and of assured quality at all times, aligning with the goals of universal health coverage. (who.int)

These developments underscore the ongoing global recognition of ciprofloxacin's importance and the need for stringent regulatory compliance to ensure its quality and accessibility worldwide.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ciprofloxacin

Retail & reference prices across 9 markets vs. India FOB export price of $14.17/unit

Global Price Benchmark for Ciprofloxacin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.44 – $1.02	USD	According to the FDA Orange Book, generic versions of Ciprofloxacin are widely available, contributing to competitive pricing.
United Kingdom	Data not available	GBP	The NHS Drug Tariff provides pricing information for medications; however, specific data for Ciprofloxacin 500mg tablets is not readily accessible.
Germany	Data not available	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) oversees pharmaceutical pricing, but specific figures for Ciprofloxacin 500mg tablets are not publicly disclosed.

Supply Chain Risk Assessment — Ciprofloxacin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of ciprofloxacin, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70-80% of India's API and KSM requirements are sourced from China, underscoring a significant dependency on Chinese suppliers. This reliance exposes the supply chain to vulnerabilities stemming from geopolitical tensions, trade disputes, and regulatory changes in China.

Recent environmental regulations in China have led to the shutdown of several chemical manufacturing facilities, disrupting the supply of essential KSMs. For instance, in July 2018, closures of Chinese companies impacted Indian pharmaceutical manufacturers, causing supply uncertainties and price increases for APIs. Such disruptions highlight the risks associated with overdependence on a single country for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of ciprofloxacin account for 45.9% of total exports, with DR. REDDY'S LABORATORIES LTD leading at a 16.1% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact global ciprofloxacin availability.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic API and KSM production. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules like Penicillin G and 6-APA, essential for antibiotics. While these initiatives are steps toward reducing import dependence, their impact on ciprofloxacin's supply chain remains to be fully realized.

Access Complete Ciprofloxacin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 14,146 transactions across 180 markets.

Request Demo View Pricing

Frequently Asked Questions — Ciprofloxacin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ciprofloxacin exporters from India?

The leading ciprofloxacin exporters from India are DR.REDDY'S LABORATORIES LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDYS LABORATORIES LIMITED, and 12 others. DR.REDDY'S LABORATORIES LTD leads with 16.1% market share ($48.5M). The top 5 suppliers together control 45.9% of total export value.

What is the total export value of ciprofloxacin from India?

The total export value of ciprofloxacin from India is $301.1M, recorded across 14,146 shipments from 1001 active exporters to 180 countries. The average shipment value is $21.3K.

Which countries import ciprofloxacin from India?

India exports ciprofloxacin to 180 countries. The top importing countries are UNITED STATES (42.3%), RUSSIA (7.1%), VIETNAM (6.9%), NIGERIA (6.1%), ETHIOPIA (2.2%), which together account for 64.6% of total export value.

What is the HS code for ciprofloxacin exports from India?

The primary HS code for ciprofloxacin exports from India is 30042013. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ciprofloxacin

Ciprofloxacin

Top Ciprofloxacin Exporters from India

Top Countries Importing Ciprofloxacin from India

Who Supplies Ciprofloxacin to India?

Quick Facts

Related Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Ciprofloxacin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ciprofloxacin

Supply Chain Risk Assessment — Ciprofloxacin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ciprofloxacin Trade Intelligence

Frequently Asked Questions — Ciprofloxacin Exports from India

Who are the top ciprofloxacin exporters from India?

What is the total export value of ciprofloxacin from India?

Which countries import ciprofloxacin from India?

What is the HS code for ciprofloxacin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ciprofloxacin exports from India?

Which ports handle ciprofloxacin exports from India?

Why is India a leading exporter of ciprofloxacin?

What certifications do Indian ciprofloxacin exporters need?

How many buyers import ciprofloxacin from India?

What is the market share of the top ciprofloxacin exporter from India?

Analysis Methodology